Skip to main content


Full Schedule

Full Schedule

  • Monday, October 16, 2023
  • 6:30 AM – 6:30 PM CT
    AABB Corporate Member Lounge
  • 6:30 AM – 6:30 PM CT
    DEIA Community Lounge
  • 6:30 AM – 6:30 PM CT
    Prayer & Meditation Room
  • 6:30 AM – 6:30 PM CT
    REGISTRATION
  • 7:00 AM – 8:15 AM CT
    Industry Workshop presented by Cerus Corporation
  • 7:00 AM – 8:15 AM CT
    Industry Workshop presented by Office of Radiological Security
  • 7:00 AM – 8:30 AM CT
    AABB Foundation R&D Summit
  • 7:00 AM – 6:00 PM CT
    Speaker Ready Room
  • 8:30 AM – 9:30 AM CT
    Blood Group Genotyping and Interpretation of Variant RBC Antigens Using Bioinformatic Tools
  • 8:30 AM – 9:30 AM CT
    Hyperhemolysis Syndrome: Recognition and Current Management Strategies of a Potentially Fatal Transfusion Complication
  • 8:30 AM – 9:30 AM CT
    Inspection Findings and Updates from FDA’s Office of Regulatory Affairs - Where Does Your Institution Rank Regarding the Most Cited Deficiencies?
  • 8:30 AM – 9:30 AM CT
    New Plasma & Platelet Transfusion Guidance for Critically Ill Children by Transfusion Anemia Expert Initiative Control Avoidance of Bleeding, TAXI-CAB
  • 8:30 AM – 9:30 AM CT
    The Next Frontier: Further Cellular Therapy Manufacturing with ISBT 128 Chain of Identity Identifier
  • 8:30 AM – 9:30 AM CT
    AM23-MN-04-L - 2023 Tibor Greenwalt Memorial Award and Lectureship
  • 8:30 AM – 9:30 AM CT
    AM23-MN-06-L - Oral Abstract - Blood Donor (Davidson Ballroom C1/2)

    Program Chair: Courtney Hopkins, DO (she/her/hers) – Vitalant

    Program Chair: Lisandro Fortuny, MD (he/him/his) – Vitalant

    CE: 0 CME (AMA Physician Credit) / 1.0 CE (Non-Physician Credit)

  • 9:30 AM – 2:30 PM CT
    Posters Open

    CE: Zero

  • 9:30 AM – 4:30 PM CT
    Exhibit Hall Open

    CE: Zero

  • 10:00 AM – 11:00 AM CT
    Equity in Healthcare Panel Discussion
  • 10:00 AM – 11:00 AM CT
    Platelet Refractoriness Management - How to Treat Refractory Patients When Nothing Else Works
  • 10:00 AM – 11:00 AM CT
    Release criteria for cellular therapy products (CTPs) prior to distribution: Practical advices that you need to know.
  • 10:00 AM – 11:00 AM CT
    Simplifying Quality Audits, Tracey Hlucky, CQA

    CE: Zero

  • 10:00 AM – 11:00 AM CT
    The Science…or Not Behind Deferrals of Blood Donors With a History of Cancer
  • 10:00 AM – 11:00 AM CT
    Weak RhD Phenotypes and RHD Genotyping: Who, What, When, Where, How?
  • 10:00 AM – 11:00 AM CT
    AM23-MN-12-L - Oral Abstract - Platelets (Grand Ballroom A2)

    Program Chair: Moritz Stolla, MD – Bloodworks NW Research Institute

    Program Chair: Elizabeth F. Stone, MD, PhD (she/her/hers) – Columbia University Irving Medical Center

    CE: 0 CME (AMA Physician Credit) / 1.0 CE (Non-Physician Credit)

  • 10:00 AM – 11:00 AM CT
    AM23-MN-13-L - Oral Abstract- RBC Component Quality (Davidson Ballroom C3)

    Program Chair: Chance J. Luckey, MD,PhD (he/him/his) – University of Virginia

    Program Chair: Connie Arthur, PhD – Brigham and Women's Hospital/Harvard Medical School

    CE: 0 CME (AMA Physician Credit) / 1.0 CE (Non-Physician Credit)

  • 11:15 AM – 12:00 PM CT
    Science & Innovation Theater presented by Sanofi
  • 11:30 AM – 12:30 PM CT
    Biomanufacturing, Rob Tressler, PhD
  • 11:30 AM – 1:00 PM CT
    AABB Foundation Research Symposium
  • 12:00 PM – 1:00 PM CT
    Curated Poster Tour 4
  • 12:00 PM – 1:30 PM CT
    Cellular Therapy Section Coordinating Committee (CTSCC) Meeting
  • 12:00 PM – 1:30 PM CT
    Patient Blood Management and Transfusion Safety Officer Subsection Meeting
  • 12:00 PM – 1:30 PM CT
    Therapeutic Apheresis Subsection Meeting
  • 12:00 PM – 1:45 PM CT
    Awards Committee Meeting
  • 12:00 PM – 1:45 PM CT
    Leadership and Administrative Subsection Meeting
  • 1:00 PM – 2:00 PM CT
    VIP Dessert Bar and Award Ceremony for CABPs (by invitation only)
  • 2:00 PM – 2:45 PM CT
    Jeff Wren, Biotherapies at AABB and CABP panel
  • 2:00 PM – 3:00 PM CT
    Developing Effective Leadership Skills for Laboratory Professionals
  • 2:00 PM – 3:00 PM CT
    Directed Donations and COVID-19 Unvaccinated Donors: Ethical Framework and Practical Considerations
  • 2:00 PM – 3:00 PM CT
    Impacting Hemovigilance and Patient Safety with a National Alloantibody Exchange
  • 2:00 PM – 3:00 PM CT
    New Insights into the Development and Consequences of RBC Alloimmunization
  • 2:00 PM – 3:00 PM CT
    Untangling the Advanced Therapies Landscape: Positioning the Community Blood Center for Success
  • 2:00 PM – 3:00 PM CT
    AM23-MN-19-L - Oral Abstract- Mouse Models (Davidson Ballroom C1/2)

    Program Chair: David Gibb – Cedars-Sinai Medical Center

    Program Chair: Krystalyn E. Hudson, PhD (she/her/hers) – Columbia University Irving Medical Center

    CE: 0 CME (AMA Physician Credit) / 1.0 CE (Non-Physician Credit)

  • 2:00 PM – 3:00 PM CT
    AM23-MN-20-L - Hemphill-Jordan award
  • 2:00 PM – 3:00 PM CT
    AM23-MN-20-L - Oral Abstract- Practical Immonuhematology (Davidson Ballroom C3)

    Program Chair: Robert Maitta, M.D., Ph.D. – University Hospitals Cleveland Medical Center, Department of Pathology

    Program Chair: Jeremy Jacobs, MD, MHS (he/him/his) – Department of Laboratory Medicine, Yale School of Medicine

    CE: 0 CME (AMA Physician Credit) / 1.0 CE (Non-Physician Credit)

  • 3:30 PM – 5:00 PM CT
    ASHI/AABB Joint Session: The Problem with Platelets: How perspectives of various practitioners involved in platelet support of refractory patients has led to continuing controversies
  • 3:30 PM – 5:00 PM CT
    Cultivating Emotional Intelligence: A Guide for Emerging Leaders - Presentation and Round Table Discussion
  • 3:30 PM – 5:00 PM CT
    Driver's Ed: Using Audits to Drive Process Improvement
  • 3:30 PM – 5:00 PM CT
    How to build a pre-hospital transfusion program between emergency medical services and a hospital-based transfusion service versus a blood center.
  • 3:30 PM – 5:00 PM CT
    Wizardry School of Antigens and Antibodies
  • 3:30 PM – 5:00 PM CT
    AM23-MN-23-L - REDS Abstract Spotlight (Room 209)

    Program Chair: Michael P. Busch, MD PhD (he/him/his) – Vitalant Research Institute

    CE: 0 CME (AMA Physician Credit) / 1.5 CE (Non-Physician Credit)

  • 3:30 PM – 5:00 PM CT
    AM23-MN-25-L - Cellular Starting Material (CSM) Forum
  • 5:30 PM – 6:30 PM CT
    Eyedrops of Human Origin (EDHO)- Guidelines for Production, Clinical Use and Regulation
  • 5:30 PM – 6:30 PM CT
    Impact of Hospital Mergers and Acquisitions on the Transfusion Service
  • 5:30 PM – 6:30 PM CT
    Moving Beyond the Label - How the MPHO Unique Identifier Improves Traceability and Enhances Biovigilance
  • 5:30 PM – 6:30 PM CT
    Novel Frontiers in Biotherapies: Exosomes (inclusive of Extracellular Vesicles) and Cytokines.
  • 5:30 PM – 6:30 PM CT
    The BLOODSAFE program: Building the future of access to safe blood in Sub-Saharan Africa
  • 5:30 PM – 6:30 PM CT
    Transfusion Transmissible Infections Monitoring System (TTIMS): Tools to Assess the Safety of the Blood Supply Over Time
  • 5:30 PM – 6:30 PM CT
    AM23-MN-36-L - Oral Abstract - Blood Components & Apheresis (Davidson Ballroom C3)

    Program Chair: Tobias Cohen, MD, PhD – New York Blood Center

    Program Chair: Mark Fung, MD, PhD – University of Vermont Medical Center

    CE: 0 CME (AMA Physician Credit) / 1.0 CE (Non-Physician Credit)

  • 5:30 PM – 6:30 PM CT
    AM23-MN-37-L - Ask the Standards
  • 6:45 PM – 7:45 PM CT
    Mock Grant Review Session
  • 6:45 PM – 7:45 PM CT
    Research and Progress (RAP) — Cold Stored Platelets Research and Progress (RAP) — Cold Stored Platelets
  • 7:30 PM – 9:30 PM CT
    AABB President's Reception (invitation only)